anne burrell glp 1 Burrell's death being investigated as a possible drug overdose Anne Burrell's Death Investigated as

PMCID: PMC6033032

Usami and K

In the LEAN trial, Liraglutide was shown to have a higher rates of NASH resolution and lower rates of fibrosis progression compared to placebo

Specific situations warrant urgent professional dietary consultation: Unintentional excessive weight loss losing more than 1 kg weekly consistently, or experiencing rapid weight loss that feels uncontrolled Inability to meet minimum calorie requirements due to severe appetite suppression, nausea, or other side effects Signs of nutritional deficiency , including unusual fatigue, weakness, hair loss, brittle nails, frequent infections, or poor wound healing Pre-existing eating disorders or disordered eating patterns, as GLP-1 medications may complicate these conditions Complex medical conditions such as chronic kidney disease, liver disease, or malabsorption disorders requiring specialised dietary management Pregnancy or breastfeeding GLP-1 medications should not be used during pregnancy